Dharoya Pharmaciuticales Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.40 M
as on 07-07-2024
- Company Age 36 Year, 28 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.55 Cr
as on 07-07-2024
- Satisfied Charges ₹ 0.43 M
as on 07-07-2024
- Revenue 47.47%
(FY 2023)
- Profit -25.74%
(FY 2023)
- Ebitda -40.28%
(FY 2023)
- Net Worth 21.52%
(FY 2023)
- Total Assets 26.91%
(FY 2023)
About Dharoya Pharmaciuticales
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹1.55 Cr. The company has closed loans amounting to ₹0.43 M, as per Ministry of Corporate Affairs (MCA) records.
Kishan Rupapara and Bhavnaben Rupapara serve as directors at the Company.
- CIN/LLPIN
U24231GJ1988PTC011555
- Company No.
011555
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Baroda, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dharoya Pharmaciuticales Pvt Ltd offer?
Dharoya Pharmaciuticales Pvt Ltd offers a wide range of products and services, including Industrial Chemicals & Supplies, Industrial Acid, Pharma Ingredients & Raw Materials, API Intermediate, Organic and Inorganic Solvents, Carboxylate Esters, Chemical Reagents & Catalysts, Bromine Compound, Rubber Chemicals, Organic Compounds.
Who are the key members and board of directors at Dharoya Pharmaciuticales?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishan Rupapara  | Director | 01-Aug-2017 | Current |
| Bhavnaben Rupapara | Director | 01-Aug-2017 | Current |
Financial Performance of Dharoya Pharmaciuticales.
Dharoya Pharmaciuticales Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 47.47% increase. The company also saw a substantial fall in profitability, with a 25.74% decrease in profit. The company's net worth Soared by an impressive increase of 21.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dharoya Pharmaciuticales?
In 2023, Dharoya Pharmaciuticales had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trinaya Lifesciences Private LimitedActive 3 months 26 daysKishan Rupapara and Bhavnaben Rupapara are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Sep 2023 | ₹1.50 M | Open |
Others Creation Date: 17 Mar 2021 | ₹1.40 Cr | Open |
Bank Of Baroda Creation Date: 02 Feb 1994 | ₹0.18 M | Satisfied |
How Many Employees Work at Dharoya Pharmaciuticales?
Unlock and access historical data on people associated with Dharoya Pharmaciuticales, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dharoya Pharmaciuticales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dharoya Pharmaciuticales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
